NCT06870760
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Clonal Hematopoiesis of Indeterminate Potential, +20 more
- Locations
-
- Levine Cancer Institute Charlotte, North Carolina, United States
Clinical trial condition
Monoclonal Gammopathy
Explore clinical trials studying Monoclonal Gammopathy. Study availability and eligibility vary by location and protocol.
10 public trials
1 recruiting study
Monoclonal Gammopathy trial results
Not Yet Recruiting
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
NCT07624760
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
- Locations
-
- University Hospital Zurich Zurich, Canton of Zurich, Switzerland
Not Yet Recruiting
Multi-center Screening for Serum M Protein
NCT06750965
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
NCT06489613
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT03820817
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Gammopathy Igg, +21 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT03832140
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- CHRU de Brest Brest, France
NCT02741999
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
Completed
Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy
NCT01543100
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Rennes University Hospital Rennes, Brittany Region, France
Active, Not Recruiting
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
NCT04614558
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Massachusetts General Hospital, Renal Associates Clinic Boston, Massachusetts, United States
- Columbia University Irving Medical Center New York, United States
Active, Not Recruiting
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
NCT03236428
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Pacific Cancer Care Monterey, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States